The Company is traded on the Nasdaq under the ticker “ICU”
SeaStar Medical officially trades under ICU on October 31st, 2022. SeaStar Medical closed the transaction on October 28th, 2022
Please contact a registered broker to purchase stock. The Company cannot sell or purchase shares directly from investors.
December 31st
To receive SeaStar Medical investor email alerts, please provide your contact information in the form on the Investor Email Alerts page.
For other inquiries, please use the form on the Contact Us page.
WithumSmith+Brown, PC
www.withum.com
Continental Stock Transfer and Trust Company
1-800-509-8856
1 State Street 30th Floor
New York, NY 10004-1561
SeaStar Medical Investor Relations:
IR@Seastarmed.com
Dorsey & Whitney LLP
111 South Main Street, Suite 2100
Salt Lake City, Utah 84111
(801) 933-7360
3513 Brighton Blvd
Suite 410
Denver, CO 80216
As a result of the reverse stock split, each 25 pre-split shares of common stock outstanding will automatically combine and convert to 1 issued and outstanding share of common stock. In other words, for every 25 ICU shares held by a stockholder prior to the reverse split, such stockholder will now hold 1 ICU share after the reverse split. As an example, a stockholder holding 100 ICU shares of common stock prior to the reverse split now holds four (4) ICU shares after the reverse stock split. Stockholders who otherwise would be entitled to receive fractional shares will receive one whole share of common stock as part of the reverse stock split in lieu of such fractional share.
In addition, the reverse stock split reduces the number of shares issuable upon exercise of public warrants (ticker symbol ICUCW), but it will not change the number of public warrants or the exercise price of such warrants. In other words, there remains the same number of ICUCW warrants outstanding before and after the reverse stock split and the exercise price for each warrant remains the same at $11.50. However, each ICUCW warrant has the right to purchase 1/25 share of ICU post reverse split. Therefore, an ICUCW warrant holder now is required to exercise 25 warrants at $11.50 exercise price per warrant, or an aggregate exercise price of $287.50, to acquire one share of ICU.
As an example, if a holder holds 100 warrants prior to the reverse split, the holder will pay $1,150 (at an exercise price of $11.50 per warrant) to exercise the warrants and receive 100 ICU shares. After the reverse stock split, the holder of 100 warrants will pay $1,150 (at an exercise price of $11.50 per warrant) to exercise the warrants and receive 4 ICU shares.
Further, there is no rounding of ICUCW warrants or issuance of fractional shares upon exercise of warrants. A holder must exercise a total of 25 warrants to receive one share of ICU common stock.